Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bult

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.
Analytical Chemistry|December 1, 1995
Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11)J L Reubsaet, J H Beijnen, A Bult, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solutionJ C Waterval, J C Bloks, R W Sparidans, et al.
Surgery|October 28, 2025
Observational training for surgical residents using visual arts in the museumThomas M van Gulik, Stella A Bult, Pien E J de Ruiter, et al.
Investigational New Drugs|January 1, 1994
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)J D Jonkman-de Vries, M J de Graaff-Teulen, R E Henrar, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Qualitative and quantitative aspects of the degradation of several tripeptides derived from the antitumour peptide antagonist [Arg(6), D-Trp(7,9), MePhe(8)] substance P[6-11]J L Reubsaet, J H Beijnen, E H Belshof, et al.
Journal of Pharmaceutical Sciences|February 9, 2000
Degradation of azaglycinamido residues in model tripeptides derived from goserelinM A Hoitink, J H Beijnen, A Bult, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.
Analytical Chemistry|December 1, 1995
Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11)J L Reubsaet, J H Beijnen, A Bult, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solutionJ C Waterval, J C Bloks, R W Sparidans, et al.
Surgery|October 28, 2025
Observational training for surgical residents using visual arts in the museumThomas M van Gulik, Stella A Bult, Pien E J de Ruiter, et al.
Investigational New Drugs|January 1, 1994
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)J D Jonkman-de Vries, M J de Graaff-Teulen, R E Henrar, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1994
Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluidD M Burger, H Rosing, C H ten Napel, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusionH Rosing, V Lustig, L J van Warmerdam, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Qualitative and quantitative aspects of the degradation of several tripeptides derived from the antitumour peptide antagonist [Arg(6), D-Trp(7,9), MePhe(8)] substance P[6-11]J L Reubsaet, J H Beijnen, E H Belshof, et al.
Journal of Pharmaceutical Sciences|February 9, 2000
Degradation of azaglycinamido residues in model tripeptides derived from goserelinM A Hoitink, J H Beijnen, A Bult, et al.
Pageof 14